Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bloch

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Current HIV/AIDS Reports|March 12, 2017
Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research UseJody Kamminga, Luxshimi Lal, Edwina J Wright, et al.
Plos One|November 3, 2011
Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or abacavir-lamivudineAllison Martin, Janaki Amin, Sean Emery, et al.
The Journal of Sexual Medicine|January 20, 2007
Quality of erection questionnaire correlates: change in erection quality with erectile function, hardness, and psychosocial measures in men treated with sildenafil for erectile dysfunctionMichael Lowy, Suzanne Collins, Mark Bloch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 28, 2012
Adherence to HIV treatment guidelines for comorbid disease assessment and initiation of antiretroviral therapyMark Bloch, Jennifer Hoy, Nicola Cunningham, et al.
Sexual Health|September 6, 2008
2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST studyNeil Bodsworth, Mark Bloch, Anna McNulty, et al.
Open Forum Infectious Diseases|July 16, 2016
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionMarianne Martinello, Gregory J Dore, Jasmine Skurowski, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|December 28, 2020
Erratum to: An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implicationsThomas M Gates, Jody Kamminga, Avindra Jayewardene, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 10, 2020
An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implicationsThomas M Gates, Jody Kamminga, Avindra Jayewardene, et al.
AIDS (London, England)|September 10, 2010
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trialAllison Martin, Janaki Amin, David A Cooper, et al.
Journal of Drugs in Dermatology : JDD|July 10, 2014
Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trialThomas Bieber, Olivier Chosidow, Neil Bodsworth, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Current HIV/AIDS Reports|March 12, 2017
Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research UseJody Kamminga, Luxshimi Lal, Edwina J Wright, et al.
Plos One|November 3, 2011
Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or abacavir-lamivudineAllison Martin, Janaki Amin, Sean Emery, et al.
The Journal of Sexual Medicine|January 20, 2007
Quality of erection questionnaire correlates: change in erection quality with erectile function, hardness, and psychosocial measures in men treated with sildenafil for erectile dysfunctionMichael Lowy, Suzanne Collins, Mark Bloch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 28, 2012
Adherence to HIV treatment guidelines for comorbid disease assessment and initiation of antiretroviral therapyMark Bloch, Jennifer Hoy, Nicola Cunningham, et al.
Sexual Health|September 6, 2008
2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST studyNeil Bodsworth, Mark Bloch, Anna McNulty, et al.
Open Forum Infectious Diseases|July 16, 2016
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionMarianne Martinello, Gregory J Dore, Jasmine Skurowski, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|December 28, 2020
Erratum to: An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implicationsThomas M Gates, Jody Kamminga, Avindra Jayewardene, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 10, 2020
An examination of reliable change methods for measuring cognitive change with the Cogstate Computerized Battery: Research and clinical implicationsThomas M Gates, Jody Kamminga, Avindra Jayewardene, et al.
AIDS (London, England)|September 10, 2010
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trialAllison Martin, Janaki Amin, David A Cooper, et al.
Journal of Drugs in Dermatology : JDD|July 10, 2014
Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trialThomas Bieber, Olivier Chosidow, Neil Bodsworth, et al.
Pageof 9